Health Canada
Symbol of the Government of Canada
Consumer Product Safety

Proposed Registration Decision PRD2012-17, Aureobasidium pullulans strain DSM 14940 and Aureobasidium pullulans strain DSM 14941

Notice to the reader: The online consultation is now closed. Comments and suggestions received during the public consultation period are being considered in the finalization of this document. The final report will be made available as soon as possible.

Pest Management Regulatory Agency
10 July 2012
ISSN: 1925-0886 (PDF version)
Catalogue number: H113-9/2012-17E-PDF (PDF version)

This page is a summary of the consultation document. If you would like to comment, please request the full consultation document.

To obtain a full copy of Proposed Registration Decision PRD2012-17, Aureobasidium pullulans strain DSM 14940 and Aureobasidium pullulans strain DSM 14941 please contact our publications office.

Should you require further information please contact the Pest Management Information Service .

Summary

Table of Contents

Proposed Registration Decision for Aureobasidium pullulans strain DSM 14940 and Aureobasidium pullulans strain DSM 14941

Health Canada's Pest Management Regulatory Agency (PMRA), under the authority of the Next link will take you to another Web site Pest Control Products Act and Next link will take you to another Web site Regulations, is proposing full registration for the sale and use of Aureobasidium pullulans DSM 14940, Aureobasidium pullulans DSM 14941 and Blossom Protect, containing the technical grade active ingredients Aureobasidium pullulans strain DSM 14940 and strain DSM 14941, to control fire blight in pome fruits and suppression of fire blight in woody Rosaceae ornamentals.

An evaluation of available scientific information found that, under the approved conditions of use, the product has value and does not present an unacceptable risk to human health or the environment.

This summary describes the key points of the evaluation, while the Science Evaluation of Proposed Registration Decision PRD2012-17, Aureobasidium pullulans strain DSM 14940 and Aureobasidium pullulans strain DSM 14941 provides detailed technical information on the human health, environmental and value assessments of Aureobasidium pullulans DSM 14940, Aureobasidium pullulans DSM 14941 and Blossom Protect.

What Does Health Canada Consider When Making a Registration Decision?

The key objective of the Pest Control Products Act is to prevent unacceptable risks to people and the environment from the use of pest control products. Health or environmental risk is considered acceptable if there is reasonable certainty that no harm to human health, future generations or the environment will result from use or exposure to the product under its proposed conditions of registration. The Act also requires that products have value when used according to the label directions. Conditions of registration may include special precautionary measures on the product label to further reduce risk.

To reach its decisions, the PMRA applies modern, rigorous risk-assessment methods and policies. These methods consider the unique characteristics of sensitive subpopulations in humans (for example, children) as well as organisms in the environment (for example, those most sensitive to environmental contaminants). These methods and policies also consider the nature of the effects observed and the uncertainties when predicting the impact of pesticides. For more information, please refer to the following:

Before making a final registration decision on Aureobasidium pullulans strain DSM 14940 and Aureobasidium pullulans strain DSM 14941, the PMRA will consider all comments received from the public in response to Proposed Registration Decision PRD2012-17, Aureobasidium pullulans strain DSM 14940 and Aureobasidium pullulans strain DSM 14941. The PMRA will then publish a Registration Decision on Aureobasidium pullulans strain DSM 14940 and Aureobasidium pullulans strain DSM 14941, which will include the decision, the reasons for it, a summary of comments received on the proposed final registration decision and the PMRA's response to these comments.

For more details on the information presented in this summary, please refer to the Science Evaluation of Proposed Registration Decision PRD2012-17, Aureobasidium pullulans strain DSM 14940 and Aureobasidium pullulans strain DSM 14941.

What Is Aureobasidium pullulans strain DSM 14940 and Aureobasidium pullulans strain DSM 14941?

Aureobasidium pullulans strains DSM 14940 and DSM 14941 are the active ingredients in the end-use product (EP), Blossom Protect. These strains of fungi are used as microbial pest control agents (MPCA) against fire blight caused by Erwinia amylovora in pome fruits and woody Rosaceae ornamentals. Both strains DSM 14940 and DSM 14941 of A. pullulans were originally isolated from apple leaves of an untreated apple plantation in Germany.

The two A. pullulans strains are living yeasts that compete against the fire blight pathogen for space and nutrients under the low pH of the spray solution provided by the citric acid buffer. The fire blight pathogen is not adapted to grow under a low pH environment.

Health Considerations

Can Approved Uses of Aureobasidium pullulans strain DSM 14940 and Aureobasidium pullulans strain DSM 14941 Affect Human Health?

Aureobasidium pullulans strain DSM 14940 and A. pullulans strain DSM 14941 are unlikely to affect your health when Blossom Protect is used according to the label directions.

People could be exposed to A. pullulans strain DSM 14940 and A. pullulans strain DSM 14941 when handling and applying Blossom Protect. When assessing health risks, several key factors are considered:

  • the microorganism's biological properties (for example, production of toxic byproducts);
  • reports of any adverse incidents;
  • its potential to cause disease or toxicity as determined in toxicological studies; and
  • the level to which people may be exposed relative to exposures already encountered in nature to other isolates of this microorganism.

Toxicological studies in laboratory animals describe potential health effects from large doses in order to identify any potential pathogenicity, infectivity and toxicity concerns. When spores of A. pullulans strain DSM 14940 and A. pullulans strain DSM 14941 were tested on laboratory animals, there were no signs that it caused any significant toxicity or disease.

Residues in Water and Food

Dietary risks from food and water are not of concern

As part of the assessment process prior to the registration of a pesticide, Health Canada must determine whether the consumption of the maximum amount of residues, that are expected to remain on food products when a pesticide is used according to label directions, will not be a concern to human health. This maximum amount of residues expected is then legally established as a maximum residue limit (MRL) under the Pest Control Products Act for the purposes of the adulteration provision of the Next link will take you to another Web site Food and Drugs Act. Health Canada sets science-based MRLs to ensure that the food Canadians eat is safe.

Aureobasidium pullulans is a ubiquitous yeast-like fungus that is commonly found in the phyllosphere. The level of A. pullulans on pome fruit is not expected to significantly increase due to the application of Blossom Protect since it is found in the phyllosphere at concentrations comparable to the application rate. Any increase in the population of A. pullulans that may occur is expected to return to natural levels at the time of harvest since application of Blossom Protect is to be made during bloom. Furthermore, when A. pullulans strain DSM 14940 and A. pullulans strain DSM 14941 were administered orally to rats, no signs of toxicity or disease were observed, and no metabolites of toxicological significance have been shown to be produced by this or other strains of A. pullulans. Therefore the establishment of a MRL is not required for A. pullulans strain DSM 14940 or A. pullulans strain DSM 14941. As well, the likelihood of residues contaminating drinking water supplies is negligible to non-existent. Consequently, dietary risks are minimal to non-existent.

Occupational Risks From Handling Blossom Protect

Occupational risks are not of concern when Blossom Protect is used according to label directions, which include protective measures

Growers handling Blossom Protect can come into direct contact with A. pullulans strain DSM 14940 and A. pullulans strain DSM 14941 on the skin, in the eyes or by inhalation. For this reason, the product labels specify that growers exposed to Blossom Protect must wear waterproof gloves, coveralls, a NIOSH-approved respirator (with any N-95, P-95, R-95 or HE filter for biological products), and shoes plus socks. Eye goggles are not required as the eye irritation studies submitted indicated minimal eye irritation potential.

For the bystander, exposure is expected to be much less than that of handlers and mixer/loaders and is considered negligible. Therefore, health risks to bystanders are not of concern.

Environmental Considerations

What Happen When Aureobasidium pullulans strain DSM 14940 and Aureobasidium pullulans strain DSM 14941 are Introduced into the Environment?

Environmental risks are not of concern

The active ingredients contained in Blossom Protect, A. pullulans strain DSM 14940 and A. pullulans strain DSM 14941, are individual isolates of the species A. pullulans which is a ubiquitous yeast-like organism. Following application, levels of A. pullulans DSM strain 14940 and A. pullulans strain DSM 14941 in the environment are comparable to observable levels of naturally occurring A. pullulans. Since naturally occurring background levels of A. pullulans vary, levels may temporarily increase after application, however, it is expected that the population of A. pullulans strain DSM 14940 and A. pullulans strain DSM 14941 would return to the site specific natural background levels over the course of the growing season.

Studies were conducted to determine the effects of A. pullulans DSM 14941 on birds and of Blossom Protect (containing A. pullulans strain DSM 14940 and A. pullulans strain DSM 14941) on fish, bees, terrestrial and aquatic arthropods, and aquatic plants. These studies showed that A. pullulans DSM 14941 was not toxic or pathogenic to birds, and that Blossom Protect was not toxic or pathogenic to fish, bees, terrestrial and aquatic arthropods, or aquatic plants.

Although terrestrial non-arthropod invertebrate, plant, and aquatic non-arthropod invertebrate, and microorganism toxicity/pathogenicity testing were not assessed in the review, adequate information was available to determine that significant adverse effects to these non-target organisms are not expected. The level of exposure to these non-target organisms from the application of Blossom Protect are expected to be comparable to exposures that could occur from natural populations of A. pullulans. Furthermore, a search of published scientific literature did not result in any reports of adverse effects to non-target organism from A. pullulans.

Value Considerations

What Is the Value of Blossom Protect?

Aureobasidium pullulans strain DSM 14940 and Aureobasidium pullulans strain DSM 14941, the active ingredients in Blossom Protect, control fire blight in pome fruits (bearing and non-bearing) and suppress fire blight in woody Rosaceae ornamentals.

Blossom Protect, containing 2.5 × 109 CFU/g A. pullulans strain DSM 14940 and 2.5 × 109 CFU/g A. pullulans strain DSM 14941, is a product formulated as a crown treatment against fire blight in pome fruits (bearing and non-bearing) and in woody Rosaceae ornamentals. A citric acid buffer is included in the formulation to ensure a consistent low pH value, which is essential for the initial growth of the A. pullulans strains.

Measures to Minimize Risk

Labels of registered pesticide products include specific instructions for use. Directions include risk-reduction measures to protect human and environmental health. These directions must be followed by law.

The key risk-reduction measures being proposed on the label of Blossom Protect to address the potential risks identified in this assessment are as follows.

Key Risk-Reduction Measures

Human Health

In individuals exposed to large quantities of Blossom Protect, respiratory and dermal sensitivity could possibly develop upon repeated exposure to the product since the end-use product has been identified as a sensitizer. Therefore, anyone handling or applying Blossom Protect must wear waterproof gloves, coveralls, a NIOSH-approved respirator (with any N-95, P-95, R-95 or HE filter for biological products), and shoes plus socks. Eye goggles are not required as the eye irritation studies submitted indicated minimal eye irritation potential. An additional risk reduction measure is a restricted entry interval for early-entry workers immediately following product application until sprays have dried. Workers may re-enter before sprays have dried if wearing appropriate personal protective equipment (PPE), including water-proof gloves, long-sleeved shirt, long pants, and shoes plus socks.

Environment

The end-use product label will include environmental precaution statements that prevent the contamination of aquatic systems from the use of Blossom Protect.

Next Steps

Before making a final registration decision on Aureobasidium pullulans strain DSM 14940 and Aureobasidium pullulans strain DSM 14941, the PMRA will consider all comments received from the public in response to Proposed Registration Decision PRD2012-17, Aureobasidium pullulans strain DSM 14940 and Aureobasidium pullulans strain DSM 14941. The PMRA will accept written comments on this proposal up to 45 days from the date of publication of Proposed Registration Decision PRD2012-17, Aureobasidium pullulans strain DSM 14940 and Aureobasidium pullulans strain DSM 14941.Please forward all comments to Publications. The PMRA will then publish a Registration Decision, which will include its decision, the reasons for it, a summary of comments received on the proposed final decision and the Agency's response to these comments.

Other Information

When the PMRA makes its registration decision, it will publish a Registration Decision on Aureobasidium pullulans strain DSM 14940 and Aureobasidium pullulans strain DSM 14941 (based on the Science Evaluation of Proposed Registration Decision PRD2012-17, Aureobasidium pullulans strain DSM 14940 and Aureobasidium pullulans strain DSM 14941). In addition, the test data referenced in this consultation document will be available for public inspection, upon application, in the PMRA's Reading Room (located in Ottawa).